Who originally held the patent for ipratropium bromide?
The original patent holder (the entity named as the patent applicant/assignee) for ipratropium bromide is not identified in the information provided here. To answer accurately, I would need at least one of the following: a patent number, a drug product trade name/mark, the jurisdiction (e.g., US, EP, UK), or the filing year.
How to find the original ipratropium bromide patent holder (what to search)
If you want the “original holder” precisely, look up the first-family patent for ipratropium bromide in a patent database and read the “assignee/applicant” field. Common places to do this include Google Patents and national patent registers.
If you share the patent number or filing jurisdiction, I can tell you exactly who the original holder was and confirm whether that holder matches the earliest priority filing.
Why “original holder” can differ from later rights holders
Even when the molecule’s first patent is owned by one company, later rights can shift due to mergers, licensing, or reorganizations. So the “original holder” for the first patent can be different from the holder of later formulation, method-of-use, or new-process patents.
If you meant the original brand manufacturer instead
Some users mean “original company behind the marketed product,” not the first molecule patent. If that’s what you meant, tell me the country and whether you mean inhaled ipratropium (e.g., for COPD/asthma) so the correct original marketing/launch entity can be identified.
Next step: Provide the patent number (or filing year and jurisdiction) you’re looking at, and I’ll identify the original patent holder for ipratropium bromide from that record.
Sources: None provided.